Long-Term Liabilities: The sum of all non-current liabilities.
Insight Molecular Diagnostics Inc. (IMDX) had Long-Term Liabilities of $42.77M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.52M |
|
$-9.74M |
|
$0.17M |
|
$0.35M |
|
$10.36M |
|
$-9.84M |
|
$0.10M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.84M |
|
$-9.28M |
|
32.02M |
|
32.02M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$26.84M |
|
$4.15M |
|
$23.68M |
|
$50.52M |
|
$6.65M |
|
-- |
|
|
Long-Term Liabilities |
$42.77M |
$49.42M |
|
$1.10M |
|
$-13.50M |
|
$1.10M |
|
28.62M |
|
| Cash Flow Statement Financials | |
$-12.14M |
|
$-0.66M |
|
$28.44M |
|
$10.34M |
|
$25.99M |
|
$15.65M |
|
$0.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
67.57% |
|
-1900.00% |
|
-1900.00% |
|
-- |
|
-1880.69% |
|
-1880.69% |
|
$-12.79M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.24 |
|
1.01 |
|
88.96 |
|
-887.25% |
|
72.15% |
|
-19.28% |
|
-887.25% |
|
$0.04 |
|
$-0.40 |
|
$-0.38 |
|